Efficacy and safety of pemetrexed maintenance chemotherapy for advanced non-small cell lung cancer in a real-world setting
CONCLUSIONS: Pemetrexed maintenance chemotherapy can improve PFS in patients with advanced nonsquamous NSCLC with good tolerability.PMID:33841970 | PMC:PMC8024837 | DOI:10.21037/jtd-21-337
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Authors: Jianjie Li Yujia Chi Guang Cao Jun Zhao Tongtong An Meina Wu Yuyan Wang Minglei Zhuo Xue Yang Bo Jia Hanxiao Chen Jingjing Wang Xiaoyu Zhai Ziping Wang Source Type: research
More News: Alimta | Cancer | Cancer & Oncology | Chemotherapy | Gastroenterology | Hematology | Liver | Lung Cancer | Non-Small Cell Lung Cancer | Respiratory Medicine | Study | Toxicology | Urology & Nephrology